COMBINATION OF INSULIN AND GLP-1 AGONIST Russian patent published in 2014 - IPC A61K38/26 A61K38/28 A61P5/50 

FIELD: medicine.

SUBSTANCE: group of inventions concerns a kit for treating diabetes comprising the first pharmaceutical composition and the second pharmaceutical composition, wherein the first pharmaceutical composition contains Gly(A21)-Arg(B31)-Arg(B32) human insulin, and the second pharmaceutical composition contains Gly(A21)-Arg(B31)-Arg(B32) human insulin and desPro³⁶exendin-4(1-39)-Lys₆-NH₂; using the kit for preparing a medicated product for treating a patient suffering from diabetes for controlling the blood glucose concentration on an empty stomach, after meals and/or after absorption, or for improving the glucose tolerance.

EFFECT: group of inventions enables achieving the synergetic effect of the combination of the above compounds.

13 cl, 14 ex, 10 dwg